{"title":"Mitigating Ethical Issues for Large Language Models in Oncology: A Systematic Review.","authors":"Shuang Zhou, Xingyi Liu, Zidu Xu, Zaifu Zhan, Meijia Song, Jun Wang, Shiao Liu, Hua Xu, Rui Zhang","doi":"10.1200/CCI-25-00076","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Large language models (LLMs) have demonstrated remarkable versatility in oncology applications, such as cancer staging and survival analysis. Despite their potential, ethical concerns such as data privacy breaches, bias in training data, lack of transparency, and risks associated with erroneous outputs pose significant challenges to their adoption in high-stakes oncology settings. Therefore, we aim to explore the ethical challenges associated with LLM-based applications in oncology and evaluate emerging techniques designed to address these issues.</p><p><strong>Methods: </strong>Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses framework, a systematic review was conducted to evaluate publications related to ethical issues of LLMs in oncology across eight academic databases (eg, PubMed, Web of Science, and Embase) between January 1, 2019, and December 31, 2024.</p><p><strong>Results: </strong>The search retrieved 4,319 published articles, of which 65 publications were preserved and included in our analysis. We identified six prevalent ethical challenges in oncology, including trust, equity, privacy, transparency, nonmaleficence, and accountability. We then evaluated emerging technical solutions to mitigate ethical challenges and summarized evaluation metrics used to assess these solutions' effectiveness.</p><p><strong>Conclusion: </strong>This review provides actionable recommendations for responsibly deploying LLMs in oncology, ensuring adherence to ethical guidelines, and fostering improved patient outcomes. By bridging technical and clinical perspectives, this review offers a foundational framework for advancing ethical artificial intelligence applications in oncology and highlights areas for future research.</p>","PeriodicalId":51626,"journal":{"name":"JCO Clinical Cancer Informatics","volume":"9 ","pages":"e2500076"},"PeriodicalIF":2.8000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JCO Clinical Cancer Informatics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1200/CCI-25-00076","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/9/24 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose: Large language models (LLMs) have demonstrated remarkable versatility in oncology applications, such as cancer staging and survival analysis. Despite their potential, ethical concerns such as data privacy breaches, bias in training data, lack of transparency, and risks associated with erroneous outputs pose significant challenges to their adoption in high-stakes oncology settings. Therefore, we aim to explore the ethical challenges associated with LLM-based applications in oncology and evaluate emerging techniques designed to address these issues.
Methods: Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses framework, a systematic review was conducted to evaluate publications related to ethical issues of LLMs in oncology across eight academic databases (eg, PubMed, Web of Science, and Embase) between January 1, 2019, and December 31, 2024.
Results: The search retrieved 4,319 published articles, of which 65 publications were preserved and included in our analysis. We identified six prevalent ethical challenges in oncology, including trust, equity, privacy, transparency, nonmaleficence, and accountability. We then evaluated emerging technical solutions to mitigate ethical challenges and summarized evaluation metrics used to assess these solutions' effectiveness.
Conclusion: This review provides actionable recommendations for responsibly deploying LLMs in oncology, ensuring adherence to ethical guidelines, and fostering improved patient outcomes. By bridging technical and clinical perspectives, this review offers a foundational framework for advancing ethical artificial intelligence applications in oncology and highlights areas for future research.
目的:大型语言模型(llm)在肿瘤分期和生存分析等肿瘤学应用中表现出了显著的多功能性。尽管它们具有潜力,但诸如数据隐私泄露、训练数据偏差、缺乏透明度以及与错误输出相关的风险等伦理问题,对它们在高风险肿瘤学环境中的采用构成了重大挑战。因此,我们的目标是探索与基于法学硕士的肿瘤学应用相关的伦理挑战,并评估旨在解决这些问题的新兴技术。方法:根据系统评价和荟萃分析框架的首选报告项目,对2019年1月1日至2024年12月31日期间8个学术数据库(如PubMed、Web of Science和Embase)中与肿瘤学法学硕士伦理问题相关的出版物进行系统评价。结果:检索到4319篇已发表文章,其中65篇被保留并纳入我们的分析。我们确定了肿瘤学中六个普遍的伦理挑战,包括信任、公平、隐私、透明度、非恶意和问责制。然后,我们评估了新兴的技术解决方案,以减轻道德挑战,并总结了用于评估这些解决方案有效性的评估指标。结论:本综述为负责任地在肿瘤学中部署法学硕士提供了可操作的建议,确保遵守伦理准则,并促进改善患者预后。通过连接技术和临床观点,本综述为推进肿瘤伦理人工智能应用提供了一个基础框架,并强调了未来的研究领域。